PMID: 9533660Apr 9, 1998Paper

Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases

Journal of Clinical Immunology
M ZelazkoR U Sorensen

Abstract

The Latin American Group for Primary Immunodeficiencies, formed in 1993, presently includes 12 countries. One goal was to study the frequency of primary immunodeficiencies in various regions of the American continent and to enhance knowledge about these diseases among primary-care physicians, as well as allergist-immunologists. Important for this purpose was the development of a registry of primary immunodeficiencies using a uniform questionnaire and computerized database. To date, eight countries have collected information on a total of 1428 patients. Predominantly antibody deficiencies were reported in 58% of patients, followed by cellular and antibody immunodeficiencies associated with other abnormalities in 18%, immunodeficiency syndromes associated with granulocyte dysfunction in 8%, phagocytic disorders in 9%, combined cellular and antibody immunodeficiencies in 5%, and complement deficiencies in 2% of patients. The information gathered from this initial analysis of data will serve to expand the patient database to more areas within participating countries and to new countries and to increase collaboration toward better diagnosis and treatment of these diseases.

Citations

Sep 1, 2005·Journal of Clinical Immunology·Davood MansouriStuart E Turvey
Jul 25, 2006·Medicine·Jerry A WinkelsteinHans D Ochs
Jun 20, 2007·Journal of Clinical Immunology·J M Boyle, R H Buckley
Jun 26, 2007·Journal of Clinical Immunology·Mahnaz Sadeghi ShabestariNima Rezaei
Mar 1, 2012·Annals of the New York Academy of Sciences·Paolo Ruggero ErranteAntonio Condino-Neto
Jul 29, 2020·Expert Review of Clinical Immunology·Hassan AbolhassaniAsghar Aghamohammadi
Jan 29, 2008·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Anthony YeeUNKNOWN Contributors to the Australian Paediatric Surveillance Unit
Dec 10, 2003·Medicine·Jerry A WinkelsteinMary Ellen Conley
Dec 28, 2006·Journal of Clinical Immunology·Lily E LeivaUNKNOWN Latin American Group for Primary Immunodeficiency Diseases
Jul 12, 2013·Journal of Clinical Immunology·Ricardo SorensenJohn B Zeiger
Nov 1, 2016·Expert Review of Clinical Immunology·Beatriz Costa-CarvalhoGesmar Segundo
Aug 31, 2001·Clinical and Diagnostic Laboratory Immunology·A López-YapO Porras
Apr 29, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Jordan S Orange
Nov 9, 2007·Current Opinion in Allergy and Clinical Immunology·Viviane Knerr, Bodo Grimbacher
Jul 14, 2006·American Journal of Reproductive Immunology : AJRI·Nima RezaeiMostafa Moin
Dec 21, 2010·Allergologia et immunopathologia·A Condino-NetoR U Sorensen
Feb 27, 2017·Allergologia et immunopathologia·I MohammadzadehN Rezaei
Oct 9, 2014·Allergologia et immunopathologia·A Condino-NetoJ L Franco
Dec 27, 2012·The World Allergy Organization Journal·Salem Al-TamemiDavid Dennison
Dec 9, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Y MinegishiM E Conley
Sep 2, 1998·Current Opinion in Immunology·M E Conley, M D Cooper
Jun 11, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Francisco A BonillaUNKNOWN Joint Council of Allergy, Asthma and Immunology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.